ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
2,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
2,2,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
2,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
3,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
3,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
4,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
5,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
7,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
7,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
7,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
8,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
9,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10,1,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
11,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
12,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
12,2,Choreoathetosis,Choreiform movements,Movement disorders (incl parkinsonism),Nerv,N
12,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
12,4,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
13,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
14,1,Gingival discolouration,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
14,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
15,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
15,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
16,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
16,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
16,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
16,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
17,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
17,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
18,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
18,2,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
19,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
20,1,Onycholysis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
21,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
22,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
22,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
23,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
23,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
24,1,Acne,Acnes,Skin appendage conditions,Skin,N
25,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
26,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
26,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
27,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
27,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
28,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
29,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
30,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
30,2,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
31,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
31,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
32,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
33,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
34,1,Proctitis,Rectal inflammations NEC,Gastrointestinal inflammatory conditions,Gastr,N
35,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
36,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
37,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
37,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
37,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
38,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
39,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
40,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
41,1,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
41,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
42,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
43,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
43,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
44,1,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
45,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
45,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
46,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
47,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
47,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
48,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
49,1,Gastric ulcer perforation,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
50,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
51,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
52,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
53,1,Ureterolithiasis,Urinary tract lithiasis NEC,Urolithiases,Renal,N
54,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
55,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
56,1,Sarcoma,Soft tissue sarcomas histology unspecified,Soft tissue neoplasms malignant and unspecified,Neopl,Y
57,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
58,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
59,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
59,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
60,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
61,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
62,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
63,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
63,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
64,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
65,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
66,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
67,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
68,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
68,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
68,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
69,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
70,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
71,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
72,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
73,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
74,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
74,2,Lip oedema,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
75,1,Headache,Headaches NEC,Headaches,Nerv,N
75,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
75,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
75,4,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
75,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
76,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
77,1,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
77,2,Hyperprolactinaemia,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
77,3,Oligomenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
78,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
79,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
80,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
81,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
82,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
82,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
83,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
83,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
84,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
84,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
85,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
86,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
86,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
87,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
88,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
89,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
90,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
91,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
92,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
92,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
93,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
94,1,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
95,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
96,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
97,1,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
98,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
98,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
99,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
100,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
101,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
101,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
102,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
102,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
103,1,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
104,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
104,2,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
104,3,Tunnel vision,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
105,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
106,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
106,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
106,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
107,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
108,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
109,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
110,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
110,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
111,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
112,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
113,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
114,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
115,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
116,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
116,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
116,3,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
117,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
117,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
118,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
119,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
119,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
120,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
121,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
122,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
123,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
123,2,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
123,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
123,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
124,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
125,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
125,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
126,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
127,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
127,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
128,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
129,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
130,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
130,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
131,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
132,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
133,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
134,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
134,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
135,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
136,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
137,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
138,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
138,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
138,3,Headache,Headaches NEC,Headaches,Nerv,N
138,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
138,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
138,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
139,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
139,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
139,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
139,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
140,1,Macule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
141,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
142,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
143,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
144,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
144,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
145,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
145,2,Metal poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
145,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
146,1,Food interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
147,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
148,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
149,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
149,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
150,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
151,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
151,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
152,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
152,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
152,3,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
153,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
154,1,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
154,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
154,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
155,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
155,2,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
155,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
156,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
157,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
158,1,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
158,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
158,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
158,4,Rectal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
159,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
160,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
160,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
160,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
161,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
161,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
161,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
161,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
162,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
163,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
163,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
163,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
163,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
163,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
164,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
164,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
164,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
165,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
165,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
166,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
167,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
168,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
169,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
169,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
170,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
171,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
171,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
171,3,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
171,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
172,1,Intracranial hypotension,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
173,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
173,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
173,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
173,4,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
173,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
174,1,Cardiac murmur,Cardiac auscultatory investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
174,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
174,3,Tongue coated,Tongue signs and symptoms,Tongue conditions,Gastr,N
175,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
175,2,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
175,3,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
176,1,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
176,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
177,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
178,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
178,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
178,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
178,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
179,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
179,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
180,1,Headache,Headaches NEC,Headaches,Nerv,N
180,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
180,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
181,1,Headache,Headaches NEC,Headaches,Nerv,N
181,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
181,3,Migraine,Migraine headaches,Headaches,Nerv,N
181,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
182,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
183,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
184,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
184,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
184,3,Impaired driving ability,Disability issues,Lifestyle issues,SocCi,N
184,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
184,5,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
184,6,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
184,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
184,8,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
184,9,Rest regimen,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
184,10,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
185,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
185,2,Macular degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
186,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
187,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
187,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
188,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
189,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
189,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
189,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
189,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
189,5,Muscle fatigue,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
189,6,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
190,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
191,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
192,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
193,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
193,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
193,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
194,1,Joint noise,Joint related signs and symptoms,Joint disorders,Musc,N
194,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
195,1,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
196,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
196,2,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
196,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
196,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
196,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
196,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
197,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
197,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
198,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
198,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
198,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
199,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
199,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
200,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
200,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
201,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
201,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
202,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
203,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
203,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
203,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
203,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
203,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
203,6,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
203,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
204,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
205,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
205,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
205,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
205,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
205,5,Pharyngeal mass,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
205,6,Reflux gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
206,1,Aortic stenosis,Aortic necrosis and vascular insufficiency,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
206,2,Blood copper increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
206,3,Cardiac failure,Heart failures NEC,Heart failures,Card,N
206,4,Manganese increased,Toxicology laboratory analyses,Toxicology and therapeutic drug monitoring,Inv,N
207,1,Foaming at mouth,General signs and symptoms NEC,General system disorders NEC,Genrl,N
207,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
208,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
208,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
208,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
209,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
210,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
211,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
211,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
211,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
212,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
212,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
213,1,Acne,Acnes,Skin appendage conditions,Skin,N
213,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
214,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
214,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
215,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
215,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
215,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
216,1,Daydreaming,Cognitive and attention disorders and disturbances NEC,Cognitive and attention disorders and disturbances,Psych,N
216,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
216,3,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
216,4,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
217,1,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
217,2,Hormone receptor positive breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
218,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
218,2,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
219,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
219,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
220,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
220,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
220,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
220,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
220,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
220,6,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
220,7,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
221,1,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
222,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
222,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
222,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
222,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
223,1,Blood magnesium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
223,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
224,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
224,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
224,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
224,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
225,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
226,1,Headache,Headaches NEC,Headaches,Nerv,N
227,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
227,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
227,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
227,4,Headache,Headaches NEC,Headaches,Nerv,N
227,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
228,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
228,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
228,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
229,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
229,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
229,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
229,4,Feeling of despair,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
229,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
229,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
229,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
229,8,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
229,9,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
229,10,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
229,11,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
230,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
230,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
230,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
231,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
232,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
232,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
232,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
232,4,Faeces pale,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
232,5,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
232,6,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
232,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
233,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
233,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
234,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
234,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
234,3,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
234,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
235,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
235,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
235,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
235,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
235,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
236,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
236,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
237,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
237,2,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
237,3,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
238,1,Application site eczema,Application site reactions,Administration site reactions,Genrl,N
238,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
238,3,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
238,4,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
238,5,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
239,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
240,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
240,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
240,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
240,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
240,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
241,1,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
241,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
241,3,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
242,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
242,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
242,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
242,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
243,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
243,2,Tonsillitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
244,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
244,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
244,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
244,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
244,5,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
245,1,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
246,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
247,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
247,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
248,1,Arrested labour,Failed labour,Maternal complications of labour and delivery,Preg,N
248,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
248,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
249,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
250,1,Somnambulism,Parasomnias,Sleep disorders and disturbances,Psych,N
251,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
251,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
251,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
251,4,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
252,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
252,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
252,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
253,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
253,2,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
253,3,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
253,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
253,5,Tongue coated,Tongue signs and symptoms,Tongue conditions,Gastr,N
254,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
254,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
255,1,International normalised ratio fluctuation,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
256,1,International normalised ratio fluctuation,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
257,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
257,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
257,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
258,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
258,2,Gastric varices haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
258,3,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
259,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
259,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
260,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
260,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
260,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
260,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
260,5,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
261,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
261,2,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
261,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
262,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
263,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
264,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
264,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
264,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
265,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
266,1,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
267,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
267,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
268,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
268,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
268,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
269,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
269,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
270,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
270,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
271,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
272,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
273,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
273,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
274,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
274,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
275,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
275,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
275,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
276,1,Acne,Acnes,Skin appendage conditions,Skin,N
277,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
277,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
278,1,Macular degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
278,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
279,1,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
279,2,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
280,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
280,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
280,3,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
280,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
280,5,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
281,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
282,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
282,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
282,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
282,4,Vitamin A increased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
283,1,Contraindication to medical treatment,Social issues NEC,Lifestyle issues,SocCi,N
283,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
283,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
284,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
285,1,Device related sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
285,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
286,1,Bacillus bacteraemia,Bacillary infections,Bacterial infectious disorders,Infec,N
287,1,Anal pruritus,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
287,2,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
287,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
288,1,Burns second degree,Thermal burns,Injuries by physical agents,Inj&P,N
288,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
289,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
289,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
289,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
290,1,Headache,Headaches NEC,Headaches,Nerv,N
290,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
291,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
291,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
291,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
291,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
291,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
292,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
292,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
293,1,Acne,Acnes,Skin appendage conditions,Skin,N
293,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
293,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
293,4,Skin discomfort,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
293,5,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
294,1,Groin infection,Infections NEC,Infections - pathogen unspecified,Infec,N
294,2,Product contamination,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
294,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
294,4,Scrotal infection,Male reproductive tract infections,Infections - pathogen unspecified,Infec,N
294,5,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
295,1,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
295,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
295,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
296,1,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
296,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
297,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
297,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
297,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
297,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
297,5,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
298,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
298,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
299,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
299,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
299,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
300,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
300,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
300,3,Exposure via eye contact,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
300,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
300,5,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
300,6,Product container issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
300,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
301,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
301,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
302,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
302,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
303,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
303,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
304,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
305,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
306,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
306,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
306,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
306,4,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
306,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
307,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
308,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
309,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
309,2,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
310,1,Infective exacerbation of chronic obstructive airways disease,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
310,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
310,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
310,4,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
310,5,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
310,6,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
310,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
310,8,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
311,1,Haemorrhoidal haemorrhage,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
312,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
312,2,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
312,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
313,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
314,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
315,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
315,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
315,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
316,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
316,2,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
317,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
318,1,Blood copper decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
318,2,Blood zinc increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
318,3,Copper deficiency,Copper metabolism disorders,Iron and trace metal metabolism disorders,Metab,N
318,4,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
318,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
318,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
319,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
319,2,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
320,1,Haemorrhoidal haemorrhage,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
321,1,Blood selenium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
321,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
322,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
323,1,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
324,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
324,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
325,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
325,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
325,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
325,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
325,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
326,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
326,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
327,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
328,1,Anal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
328,2,Anorectal discomfort,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
328,3,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
329,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
330,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
330,2,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
330,3,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
330,4,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
330,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
330,6,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
331,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
331,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
331,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
331,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
332,1,General physical condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
332,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
333,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
333,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
334,1,Anal injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
334,2,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
335,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
336,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
336,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
337,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
338,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
338,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
339,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
339,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
339,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
339,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
339,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
340,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
341,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
342,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
343,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
343,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
343,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
344,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
344,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
345,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
345,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
345,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
345,4,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
345,5,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
345,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
345,7,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
345,8,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
345,9,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
345,10,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
345,11,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
345,12,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
345,13,Sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,N
345,14,Sleep terror,Parasomnias,Sleep disorders and disturbances,Psych,N
346,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
346,2,Peptic ulcer,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
347,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
347,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
348,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
349,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
349,2,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
349,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
349,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
350,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
350,2,Headache,Headaches NEC,Headaches,Nerv,N
350,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
351,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
351,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
351,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
351,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
351,5,Tension,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
352,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
353,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
353,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
353,3,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
353,4,Hypervitaminosis D,Hypervitaminoses NEC,Vitamin related disorders,Metab,N
353,5,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
353,6,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
353,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
353,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
354,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
355,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
356,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
357,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
357,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
358,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
358,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
358,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
359,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
359,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
360,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
360,2,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
360,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
360,4,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
360,5,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
360,6,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
360,7,Placental insufficiency,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
360,8,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
360,9,Premature separation of placenta,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
360,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
360,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
361,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
362,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
363,1,Acne,Acnes,Skin appendage conditions,Skin,N
363,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
364,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
364,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
364,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
364,4,Refeeding syndrome,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
364,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
365,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
365,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
366,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
366,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
366,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
366,4,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
366,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
367,1,Haemorrhoidal haemorrhage,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
368,1,Anal injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
368,2,Anal pruritus,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
369,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
369,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
370,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
371,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
371,2,Bradyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
371,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
372,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
373,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
374,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
374,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
374,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
375,1,Anal inflammation,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
375,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
375,3,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
375,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
375,5,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
375,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
375,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
375,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
376,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
377,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
377,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
377,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
378,1,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
379,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
380,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
380,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
380,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
380,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
380,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
381,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
381,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
381,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
382,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
382,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
382,3,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
382,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
382,5,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
382,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
382,7,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
383,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
383,2,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
384,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
384,2,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
385,1,Administration site rash,Administration site reactions NEC,Administration site reactions,Genrl,N
386,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
386,2,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
386,3,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
387,1,Burns fourth degree,Thermal burns,Injuries by physical agents,Inj&P,Y
387,2,Product caught fire,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
388,1,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
388,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
388,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
388,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
389,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
389,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
390,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
390,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
391,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
391,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
391,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
391,4,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
391,5,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
392,1,Anal pruritus,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
392,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
392,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
393,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
393,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
394,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
394,2,Headache,Headaches NEC,Headaches,Nerv,N
394,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
394,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
395,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
396,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
397,1,Device related sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
397,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
397,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
398,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
398,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
398,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
398,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
399,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
400,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
401,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
401,2,Vulvovaginal burning sensation,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
402,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
402,2,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
403,1,Migraine,Migraine headaches,Headaches,Nerv,N
403,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
403,3,Product after taste,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
403,4,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
404,1,Administration site irritation,Administration site reactions NEC,Administration site reactions,Genrl,N
405,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
405,2,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
406,1,Diabetic foot,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
407,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
408,1,Haemorrhoidal haemorrhage,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
409,1,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
410,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
411,1,Hypovitaminosis,Vitamin deficiencies NEC,Vitamin related disorders,Metab,N
411,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
412,1,Administration site erythema,Administration site reactions NEC,Administration site reactions,Genrl,N
412,2,Administration site hypersensitivity,Administration site reactions NEC,Administration site reactions,Genrl,N
413,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
413,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
413,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
414,1,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
414,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
414,3,Vulvovaginal burning sensation,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
415,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
415,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
415,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
416,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
417,1,Catheter site extravasation,Implant and catheter site reactions,Administration site reactions,Genrl,N
417,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
418,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
419,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
419,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
419,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
419,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
419,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
419,6,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
420,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
420,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
421,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
421,2,Urine calcium,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
421,3,Urine calcium,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
422,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
423,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
423,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
423,3,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
424,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
424,2,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
424,3,Ischaemic cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
424,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
425,1,Abdominal sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
425,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
425,3,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
425,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
425,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
426,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
427,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
427,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
427,3,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
428,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
428,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
428,3,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
429,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
429,2,Genital haemorrhage,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
429,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
429,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
429,5,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
430,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
430,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
430,3,Headache,Headaches NEC,Headaches,Nerv,N
431,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
432,1,Lip blister,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
432,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
432,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
433,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
433,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
434,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
434,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
435,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
435,2,Headache,Headaches NEC,Headaches,Nerv,N
435,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
435,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
436,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
437,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
437,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
438,1,Autoimmune disorder,Autoimmune disorders NEC,Autoimmune disorders,Immun,N
438,2,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
438,3,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
438,4,Hepatic mass,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
439,1,Anorectal discomfort,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
439,2,Anorectal swelling,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
439,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
440,1,Steatorrhoea,Malabsorption syndromes,Malabsorption conditions,Gastr,N
441,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
442,1,Perioral dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
443,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
444,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
445,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
446,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
447,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
447,2,Product container issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
448,1,Copper deficiency,Copper metabolism disorders,Iron and trace metal metabolism disorders,Metab,N
448,2,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
448,3,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
449,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
449,2,Cor pulmonale acute,Right ventricular failures,Heart failures,Card,N
449,3,Inadequate aseptic technique in manufacturing of product,Manufacturing production issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
450,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
450,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
451,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
452,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
453,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
453,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
453,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
453,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
454,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
454,2,Headache,Headaches NEC,Headaches,Nerv,N
454,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
454,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
455,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
455,2,Headache,Headaches NEC,Headaches,Nerv,N
455,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
455,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
455,5,Refeeding syndrome,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
456,1,Headache,Headaches NEC,Headaches,Nerv,N
456,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
456,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
457,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
458,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
458,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
459,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
460,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
461,1,Anorectal swelling,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
461,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
461,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
461,4,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
461,5,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
461,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
461,7,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
461,8,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
461,9,Vulvovaginal swelling,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
462,1,Headache,Headaches NEC,Headaches,Nerv,N
462,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
463,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
463,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
463,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
463,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
463,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
464,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
465,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
465,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
465,3,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
466,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
466,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
466,3,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
466,4,Pubic pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
466,5,Vaccination site pain,Vaccination site reactions,Administration site reactions,Genrl,N
467,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
467,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
467,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
468,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
468,2,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
469,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
469,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
469,3,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
470,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
470,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
470,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
470,4,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
471,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
471,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
472,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
473,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
473,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
474,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
475,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
475,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
475,3,Dermatitis diaper,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
475,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
476,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
477,1,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
477,2,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
478,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
478,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
479,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
479,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
479,3,Perioral dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
479,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
480,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
480,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
480,3,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
480,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
481,1,Drop attacks,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
481,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
481,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
481,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
481,5,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
481,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
482,1,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
482,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
483,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
483,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
483,3,Gastrointestinal inflammation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
484,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
484,2,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
485,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
485,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
486,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
487,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
487,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
487,3,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
487,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
487,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
488,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
488,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
489,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
489,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
489,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
490,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
491,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
492,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
492,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
492,3,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
492,4,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
492,5,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
492,6,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
492,7,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
492,8,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
492,9,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
492,10,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
492,11,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
492,12,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
492,13,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
492,14,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
492,15,Food poisoning,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
492,16,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
492,17,Genital pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
492,18,Genital ulceration,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
492,19,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
492,20,Inflammation,Inflammations,General system disorders NEC,Genrl,N
492,21,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
492,22,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
492,23,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
492,24,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
492,25,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
492,26,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
492,27,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
492,28,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
492,29,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
492,30,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
492,31,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
492,32,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
492,33,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
492,34,Pulmonary pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
492,35,Radiation inflammation,Radiation injuries,Injuries by physical agents,Inj&P,N
492,36,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
492,37,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,Y
492,38,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
493,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
494,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
494,2,Blister rupture,Bullous conditions,Epidermal and dermal conditions,Skin,N
494,3,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
494,4,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
494,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
495,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
495,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
495,3,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
495,4,Headache,Headaches NEC,Headaches,Nerv,N
495,5,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
495,6,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
495,7,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
495,8,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
495,9,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
495,10,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
495,11,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
495,12,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
495,13,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
496,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
497,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
498,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
499,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
500,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
500,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
501,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
501,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
501,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
501,4,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
501,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
502,1,Cyanopsia,Visual colour distortions,Vision disorders,Eye,N
502,2,Headache,Headaches NEC,Headaches,Nerv,N
502,3,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
503,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
503,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
504,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
504,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
505,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
505,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
506,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,Y
507,1,Metal poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
507,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
508,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
508,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
508,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
508,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
508,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
509,1,Anorectal swelling,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
509,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
509,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
509,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
510,1,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
510,2,Systemic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
511,1,Acne,Acnes,Skin appendage conditions,Skin,N
511,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
512,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
513,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
514,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
514,2,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
514,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
514,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
514,5,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
515,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
515,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
515,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
515,4,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
515,5,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
516,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
516,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
516,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
516,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
517,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
517,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
517,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
517,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
517,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
517,6,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
517,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
517,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
518,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
518,2,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
519,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
519,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
519,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
520,1,Application site discomfort,Application site reactions,Administration site reactions,Genrl,N
520,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
520,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
521,1,Blood testosterone increased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
521,2,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
521,3,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
522,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
522,2,Faeces hard,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
522,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
522,4,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
522,5,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
523,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
523,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
524,1,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
525,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
526,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
526,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
526,3,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
527,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
527,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
528,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
528,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
528,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
529,1,Product package associated injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
529,2,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
530,1,Cardiac flutter,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
531,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
531,2,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
532,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
532,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
532,3,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
532,4,Application site pain,Application site reactions,Administration site reactions,Genrl,N
532,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
533,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
534,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
535,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
535,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
536,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
537,1,Application site discomfort,Application site reactions,Administration site reactions,Genrl,N
538,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
539,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
539,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
539,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
539,4,Morning sickness,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
539,5,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
539,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
540,1,Dermo-hypodermitis,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
541,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
542,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
542,2,Impetigo,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
542,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
543,1,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
543,2,Pruritus genital,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
544,1,Anastomotic ulcer,Gastrointestinal and hepatobiliary procedural complications,Procedural related injuries and complications NEC,Inj&P,N
544,2,Anastomotic ulcer haemorrhage,Gastrointestinal and hepatobiliary procedural complications,Procedural related injuries and complications NEC,Inj&P,N
544,3,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
544,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
545,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
546,1,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
546,2,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
547,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
547,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
548,1,Blood zinc increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
549,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
549,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
550,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
551,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
551,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
552,1,Anal blister,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
552,2,Anal erythema,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
552,3,Anorectal discomfort,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
552,4,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
553,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
554,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
554,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
555,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
555,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
556,1,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
557,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
558,1,Aortic embolus,Aortic embolism and thrombosis,Embolism and thrombosis,Vasc,N
558,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
559,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
559,2,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
559,3,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
560,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
560,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
561,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
561,2,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
561,3,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
561,4,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
561,5,Vaccination site hypoaesthesia,Vaccination site reactions,Administration site reactions,Genrl,N
562,1,Product after taste,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
563,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
564,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
564,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
565,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
565,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
565,3,Weight gain poor,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
566,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
566,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
566,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
566,4,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
566,5,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
567,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
568,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
568,2,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
568,3,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
569,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
569,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
569,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
569,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
570,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
570,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
571,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
572,1,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
572,2,Packaging design issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
573,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
573,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
573,3,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
574,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
575,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
575,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
575,3,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
575,4,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
576,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
576,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
577,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
577,2,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
578,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
578,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
579,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
579,2,Application site paraesthesia,Application site reactions,Administration site reactions,Genrl,N
580,1,Anal blister,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
580,2,Anorectal discomfort,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
580,3,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
580,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
581,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
582,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
583,1,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
584,1,Headache,Headaches NEC,Headaches,Nerv,N
584,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
585,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
585,2,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
586,1,Anorectal discomfort,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
586,2,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
587,1,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
588,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
588,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
589,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
590,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
590,2,Amyloid arthropathy,Arthropathies NEC,Joint disorders,Musc,N
590,3,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
590,4,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
590,5,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
590,6,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
590,7,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
590,8,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
590,9,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
590,10,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
590,11,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
590,12,Pulmonary pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
590,13,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
591,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
591,2,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
591,3,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
591,4,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
591,5,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
591,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
591,7,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
591,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
591,9,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
591,10,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
591,11,Pulmonary pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
591,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
592,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
593,1,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
594,1,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
595,1,Infusion site pruritus,Infusion site reactions,Administration site reactions,Genrl,N
595,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
596,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
597,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
597,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
598,1,Headache,Headaches NEC,Headaches,Nerv,N
598,2,Headache,Headaches NEC,Headaches,Nerv,N
598,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
598,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
599,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
599,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
599,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
600,1,Anal pruritus,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
600,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
601,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
601,2,Acne,Acnes,Skin appendage conditions,Skin,N
601,3,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
601,4,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
601,5,Sleep terror,Parasomnias,Sleep disorders and disturbances,Psych,N
602,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
603,1,Anal erythema,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
603,2,Anal pruritus,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
603,3,Anorectal swelling,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
603,4,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
603,5,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
603,6,Vulvovaginal erythema,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
603,7,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
603,8,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
603,9,Vulvovaginal rash,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
603,10,Vulvovaginal swelling,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
604,1,Seborrhoeic dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
604,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
605,1,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
606,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
607,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
608,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
609,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
609,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
610,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
610,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
610,3,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
611,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
611,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
612,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
613,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
613,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
613,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
614,1,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
615,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
615,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
616,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
617,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
617,2,Barrett's oesophagus,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
617,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
617,4,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
617,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
617,6,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
617,7,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
617,8,Regurgitation,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
617,9,Vitamin B12 deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
618,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
619,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
620,1,Eye contusion,Eye injuries NEC,Injuries NEC,Inj&P,N
620,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
621,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
621,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
622,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
623,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
623,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
623,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
624,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
624,2,Cestode infection,Cestode infections,Helminthic disorders,Infec,N
624,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
625,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
626,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
626,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
627,1,Application site scab,Application site reactions,Administration site reactions,Genrl,N
627,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
627,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
627,4,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
628,1,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
629,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
629,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
629,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
629,4,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
629,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
629,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
629,7,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
630,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
631,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
632,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
633,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
634,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
635,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
635,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
635,3,Headache,Headaches NEC,Headaches,Nerv,N
635,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
636,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
636,2,Blood iron decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
636,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
637,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
637,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
637,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
638,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
638,2,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
639,1,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
640,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
640,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
641,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
641,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
642,1,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
642,2,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
643,1,Anal blister,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
644,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
644,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
645,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
646,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
647,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
648,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
648,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
649,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
649,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
650,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
651,1,Anorectal discomfort,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
652,1,Anal inflammation,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
652,2,Anal injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
652,3,Cardiac discomfort,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
652,4,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
652,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
652,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
652,7,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
652,8,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
652,9,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
652,10,Suffocation feeling,Respiratory signs and symptoms NEC,Respiratory tract signs and symptoms,Resp,N
652,11,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
653,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
653,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
653,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
654,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
654,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
655,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
655,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
655,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
656,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
656,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
656,3,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
656,4,Copper deficiency,Copper metabolism disorders,Iron and trace metal metabolism disorders,Metab,N
656,5,Dorsal ramus syndrome,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
656,6,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
656,7,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
656,8,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
656,9,Myelopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
656,10,Normocytic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
656,11,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
656,12,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
657,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
657,2,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
657,3,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
657,4,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
657,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
657,6,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
657,7,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
657,8,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
657,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
657,10,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
657,11,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
657,12,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
657,13,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
658,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
659,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
659,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
659,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
660,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
660,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
660,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
661,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
661,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
661,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
661,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
661,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
661,6,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
662,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
662,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
662,3,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
662,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
662,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
662,6,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
663,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
663,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
664,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
664,2,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
665,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
665,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
665,3,Hypervitaminosis,Hypervitaminoses NEC,Vitamin related disorders,Metab,N
665,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
666,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
666,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
666,3,Hypervitaminosis,Hypervitaminoses NEC,Vitamin related disorders,Metab,N
666,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
667,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
667,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
667,3,Hypervitaminosis,Hypervitaminoses NEC,Vitamin related disorders,Metab,N
667,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
668,1,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
668,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
669,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
669,2,Dermatitis diaper,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
670,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
670,2,Blister rupture,Bullous conditions,Epidermal and dermal conditions,Skin,N
670,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
670,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
671,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
671,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
671,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
671,4,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
671,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
671,6,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
671,7,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
672,1,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
672,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
672,3,Application site ulcer,Application site reactions,Administration site reactions,Genrl,N
672,4,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
672,5,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
673,1,Vulvovaginal burning sensation,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
674,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
675,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
675,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
675,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
676,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
676,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
677,1,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
678,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
678,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
678,3,Application site paraesthesia,Application site reactions,Administration site reactions,Genrl,N
678,4,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
678,5,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
678,6,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
679,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
679,2,Amyloid arthropathy,Arthropathies NEC,Joint disorders,Musc,N
679,3,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
679,4,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
679,5,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
679,6,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
679,7,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
679,8,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
679,9,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
679,10,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
679,11,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
679,12,Pulmonary pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
679,13,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
680,1,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
680,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
681,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
681,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
682,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
682,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
682,3,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
682,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
682,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
682,6,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
683,1,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
683,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
683,3,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
683,4,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
683,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
683,6,Skin discomfort,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
683,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
684,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
684,2,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
684,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
684,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
685,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
686,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
687,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
688,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
688,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
689,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
690,1,Abnormal faeces,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
690,2,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
690,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
691,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
692,1,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
693,1,Anorectal discomfort,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
694,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
695,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
695,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
695,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
696,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
697,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
697,2,Copper deficiency,Copper metabolism disorders,Iron and trace metal metabolism disorders,Metab,N
697,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
697,4,Fine motor skill dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
697,5,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
698,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
698,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
698,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
698,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
698,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
699,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
700,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
700,2,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
700,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
701,1,Headache,Headaches NEC,Headaches,Nerv,N
702,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
702,2,Copper deficiency,Copper metabolism disorders,Iron and trace metal metabolism disorders,Metab,N
702,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
702,4,Fine motor skill dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
702,5,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
703,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
703,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
703,3,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
703,4,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
703,5,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
703,6,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
703,7,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
703,8,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
703,9,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
703,10,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
703,11,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
703,12,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
703,13,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
703,14,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
703,15,Food poisoning,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
703,16,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
703,17,Genital pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
703,18,Genital ulceration,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
703,19,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
703,20,Inflammation,Inflammations,General system disorders NEC,Genrl,N
703,21,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
703,22,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
703,23,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
703,24,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
703,25,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
703,26,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
703,27,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
703,28,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
703,29,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
703,30,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
703,31,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
703,32,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
703,33,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
703,34,Pulmonary pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
703,35,Radiation inflammation,Radiation injuries,Injuries by physical agents,Inj&P,N
703,36,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
703,37,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
703,38,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
704,1,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
704,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
705,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
706,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
706,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
706,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
707,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
707,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
708,1,Anal cancer,Anal canal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
709,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
710,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
710,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
710,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
711,1,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
711,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
711,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
712,1,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
713,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
713,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
714,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
714,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
715,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
716,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
716,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
716,3,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
716,4,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
716,5,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
716,6,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
716,7,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
716,8,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
716,9,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
716,10,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
716,11,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
716,12,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
716,13,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
716,14,Klebsiella test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
716,15,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
717,1,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
718,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
718,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
719,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
719,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
720,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
720,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
720,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
721,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
721,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
721,3,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
722,1,Documented hypersensitivity to administered product,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
722,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
722,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
722,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
722,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
722,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
723,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
724,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
725,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
726,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
726,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
727,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
727,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
727,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
728,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
728,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
729,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
730,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
731,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
731,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
731,3,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
732,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
733,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
734,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
734,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
735,1,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
735,2,Liquid product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
736,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
737,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
737,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
737,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
737,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
738,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
738,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
739,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
740,1,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
741,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
742,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
742,2,Product odour abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
743,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
744,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
744,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
744,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
745,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
746,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
746,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
746,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
747,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
748,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
748,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
749,1,Accidental exposure to product by child,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
749,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
750,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
751,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
751,2,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
752,1,Nail infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
752,2,Nail operation,Nail therapeutic procedures,Skin and subcutaneous tissue therapeutic procedures,Surg,N
752,3,Onycholysis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
752,4,Onychomalacia,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
753,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
753,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
754,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
755,1,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
756,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
757,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
758,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
758,2,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
759,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
759,2,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
760,1,Anal erythema,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
760,2,Anal inflammation,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
760,3,Anal pruritus,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
760,4,Anorectal discomfort,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
760,5,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
760,6,Skin wound,Skin injuries NEC,Injuries NEC,Inj&P,N
761,1,Anorectal discomfort,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
762,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
762,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
763,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
763,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
763,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
763,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
763,5,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
764,1,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
765,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
766,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
766,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
767,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
767,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
767,3,Headache,Headaches NEC,Headaches,Nerv,N
767,4,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
768,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
769,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
769,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
769,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
769,4,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
769,5,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
770,1,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
771,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
771,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
771,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
772,1,Habit cough,Somatic symptom disorders,Somatic symptom and related disorders,Psych,N
773,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
774,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
774,2,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
774,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
775,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
775,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
775,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
775,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
776,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
776,2,Device issue,Device issues NEC,Device issues,Prod,N
776,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
777,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
778,1,Anorectal discomfort,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
779,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
779,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
780,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
781,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
782,1,Hepatic pain,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
783,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
784,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
784,2,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
785,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
785,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
785,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
785,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
785,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
785,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
786,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
786,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
786,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
787,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
788,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
788,2,Amyloid arthropathy,Arthropathies NEC,Joint disorders,Musc,N
788,3,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
788,4,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
788,5,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
788,6,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
788,7,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
788,8,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
788,9,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
788,10,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
788,11,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
788,12,Pulmonary pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
788,13,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
789,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
789,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
790,1,Anal inflammation,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
791,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
791,2,Amyloid arthropathy,Arthropathies NEC,Joint disorders,Musc,N
791,3,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
791,4,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
791,5,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
791,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
791,7,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
791,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
791,9,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
791,10,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
791,11,Pulmonary pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
791,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
792,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
793,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
794,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
794,2,Headache,Headaches NEC,Headaches,Nerv,N
794,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
794,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
795,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
795,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
795,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
795,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
795,5,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
796,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
796,2,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
797,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
798,1,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
798,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
799,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
799,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
799,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
800,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
801,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
